AP - FDA review spotlights heart risk of diabetes pill

N

NewsBot

Guest
By MATTHEW PERRONE 2010-07-10T06:24:14ZWASHINGTON (AP) -- Federal health scientists have panned a GlaxoSmithKline study that the company used to defend the safety of its embattled diabetes drug Avandia, a once blockbuster-seller that has fallen out of favor because of potential ties to heart attacks....

View the full article
 

Similar threads

N
AP - FDA keeps diabetes pill with heart risks on market
Replies
0
Views
18
NewsBot
N
N
AP - US restricts, EU bans controversial diabetes pill
Replies
0
Views
27
NewsBot
N
H
Bush's FDA pulled reviewer off Glaxo drug
Replies
0
Views
17
Harry Hope
H
L
coreg failure heart medication free pravachol lisinopril medication
Replies
0
Views
22
lesbianskstardoll@gmail.com
L
B
Pharmas Urged to Reform Test Procedures - But FDA Quirks Drive Bad Behavior
Replies
0
Views
16
B1ackwater
B
Back
Top